The landscape of cancer diagnostics has witnessed transformative advancements, particularly in the realm of human epidermal growth factor receptor 2...
In an era where early cancer detection defines the edge of clinical success, a groundbreaking study published in BMC Cancer...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and...
The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances...
In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded...
The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled...
The relentless challenge posed by glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, continues to galvanize oncological...
Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of oncology by harnessing the body's immune system to combat malignancies....
In a groundbreaking study published in BMC Cancer, researchers unveil the pivotal role of a circular RNA, circSLC22A3, in suppressing...
As of January 1, 2025, it is estimated that nearly 18.6 million individuals in the United States are living with...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine